ZNS Siegen im MVZ Weidenau
Siegen, Germany
Appraiser in Siegen, North Rhine-Westphalia
Weidenauer Str. 84, 57076 Siegen
About ZNS Siegen im MVZ Weidenau
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Biogen
2
Hoffmann-La Roche
2
Genentech, Inc.
1
Janssen-Cilag Ltd.
1
Clinical Trials at ZNS Siegen im MVZ Weidenau
During the past decade, ZNS Siegen im MVZ Weidenau conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
2012-10-24
2015-06-12
Completed
542
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-09-15
2019-08-05
Terminated
1,643
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
2017-10-04
2021-01-15
Terminated
457
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
2020-03-02
2025-02-03
Active, not recruiting
1,696
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at ZNS Siegen im MVZ Weidenau
According to Clinical.Site data, the most researched conditions in "ZNS Siegen im MVZ Weidenau" are
"Alzheimer's Disease" (4 trials), "Alzheimer Disease" (1 trials) and "Depressive Disorder, Treatment-Resistant" (1 trials). Many other conditions were trialed in "ZNS Siegen im MVZ Weidenau" in a lesser frequency.
Clinical Trials Intervention Types at ZNS Siegen im MVZ Weidenau
Most popular intervention types in "ZNS Siegen im MVZ Weidenau" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Aducanumab" (1 trials), "Aducanumab (BIIB037)" (1 trials), "Donepezil" (1 trials) and "Galantamine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ZNS Siegen im MVZ Weidenau
The vast majority of trials in "ZNS Siegen im MVZ Weidenau" are
6 trials for "All" genders.
Clinical Trials Status at ZNS Siegen im MVZ Weidenau
Currently, there are NaN active trials in "ZNS Siegen im MVZ Weidenau".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in ZNS Siegen im MVZ Weidenau,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in ZNS Siegen im MVZ Weidenau, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".